Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 5104-5107, November 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicotera, T.
Right arrow Articles by Dandona, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicotera, T.
Right arrow Articles by Dandona, P.

Elevated Production of Active Oxygen in Bloom's Syndrome Cell Lines1

Thomas Nicotera2, Kuldip Thusu and Paresh Dandona

Biophysics Department, Roswell Park Cancer Institute, Buffalo, New York 14263 [T. N.], and Department of Medicine, Millard Filmore Hospitals, Buffalo, New York 14209 [K. T., P. D.]

Based on our previous evidence indicating that the elevated sister chromatid exchange that characterizes Bloom syndrome (BS) cells may arise in response to elevated production of active oxygen, we have quantitated the levels of active oxygen in two control, two BS and one BS revertant cell lines. Luminol-dependent chemiluminescence was used as a measure of active oxygen production following treatment of the cells with the calcium ionophore A23187 or the chemotactic tripeptide N-formylmethionylleucylphenylalanine. A peptide factor present in plasma was required for priming the cells to undergo the oxidative response. As determined with A23187, active oxygen production was elevated in BS cell lines by 48.6% above control. Using N-formylmethionylleucylphenylalanine, active oxygen production was found to be increased by 250–314%. Chemiluminescence was inhibited in a dose-dependent manner by diphenylene iodonium, which specifically binds to and inhibits membrane-associated NADPH oxidase activity. This compound inhibited oxygen radical production nearly 3 times more effectively in control cells than in BS cells. The capacity to produce elevated levels of oxygen radicals may contribute to the spontaneous chromosomal instability of BS cells and to the associated high incidence of neoplasia in individuals with BS.

1 This work was aided by Institutional Grant IN-54-29 of the American Cancer Society and by a grant from the Buffalo Medical Foundation.

2 To whom requests for reprints should be addressed, at Biophysics Department, Roswell Park Memorial Institute, Elm and Carlton Streets, Buffalo, NY 14263.

Received 8/30/93. Accepted 9/17/93.




This article has been cited by other articles:


Home page
Diabetes CareHome page
H. Ghanim, P. Mohanty, R. Pathak, A. Chaudhuri, C. L. Sia, and P. Dandona
Orange Juice or Fructose Intake Does Not Induce Oxidative and Inflammatory Response
Diabetes Care, June 1, 2007; 30(6): 1406 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.